Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 9, Issue 4 (2020)

A review of the 2019 novel coronavirus (COVID-19) based on current evidence

Author(s):
Vaishali S Jagtap, Pallavi More and Dr. Urmilesh Jha
Abstract:
Coronavirus (COVID-19) is an enveloped RNA virus that is diversely found in humans and wild life. A total of six species have been identified to cause disease in humans. They are known to infect the neurological, respiratory, enteric, and hepatic systems. The past few decades have seen endemic outbreaks in the form of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome Related Coronavirus (SARS-CoV). Yet again, we see the emergence of another outbreak due to a new strain called the SARS-CoV-2 virus. The most recent outbreak initially presented as pneumonia of unknown etiology in a cluster of patients in Wuhan, China. The epicenter of infection was linked to seafood and exotic animal wholesale markets in the city. SARS-CoV-2 is highly contagious and has resulted in a rapid pandemic of COVID-19. As the number of cases continues to rise, it is clear that these viruses pose a threat to public health. This review will introduce a general overview of coronavirus and describe the clinical features, evaluation, and treatment of COVID-19 patients. It will also provide a means to raise awareness among primary and secondary healthcare providers during the current pandemic. Furthermore, our review focuses on the most up-to-date clinical information for the effective management, prevention, and counseling of patients worldwide.
Pages: 07-10  |  134 Views  20 Downloads
How to cite this article:
Vaishali S Jagtap, Pallavi More and Dr. Urmilesh Jha. . The Pharma Innovation Journal. 2020; 9(4): 07-10.
Journals List Click Here Research Journals Research Journals
Call for book chapter
The Pharma Innovation Journal